Antihypertensive medication adherence and mortality according to ethnicity: A cohort study

Canadian Journal of Cardiology

Volumn 30, Issue 8, 2014, Pages 925-931

  Liu, Qing ^a   Quan, Hude ^b   Chen, Guanmin ^b   Qian, Hong ^c   Khan, Nadia ^d  

^a WUHAN UNIVERSITY   (China)

^b UNIVERSITY OF CALGARY   (Canada)

^c Center for Health Evaluation and Outcome Sciences   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; ASIAN; CARDIOVASCULAR MORTALITY; CHINESE; CHRONIC LUNG DISEASE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; ETHNIC GROUP; FEMALE; HEART INFARCTION; HEMIPLEGIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PARAPLEGIA; RETROSPECTIVE STUDY; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; CANADA; COHORT STUDIES; COMORBIDITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEMIPLEGIA; HUMANS; HYPERTENSION; INCOME; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MYOCARDIAL INFARCTION; PARAPLEGIA; RETROSPECTIVE STUDIES;

EID: 84904757482     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.04.017     Document Type: Article

References (47)

1. Lawes C.M., Vander Hoorn S., Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet 2008, 371:1513-1518.
2. Liu R., So L., Mohan S., et al. Cardiovascular risk factors in ethnic populations within Canada: results from national cross-sectional surveys. Open Med 2010, 4:10.
3. Sheth T., Nair C., Nargundkar M., et al. Cardiovascular and cancer mortality among Canadians of European, south Asian and Chinese origin from 1979 to 1993: an analysis of 1.2 million deaths. CMAJ 1999, 161:132-138.
4. Psaty B.M., Lumley T., Furberg C.D., et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003, 289:2534-2544.
5. van Vark L.C., Bertrand M., Akkerhuis K.M., et al. Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients. Eur Heart J 2012, 33:2088-2097.
6. Burke L.E., Dunbar-Jacob J. Adherence to medication, diet, and activity recommendations: from assessment to maintenance. J Cardiovasc Nurs 1995, 9:62-79.
7. Esposti L.D., Di Martino M., Saragoni S., et al. Pharmacoeconomics of antihypertensive drug treatment: an analysis of how long patients remain on various antihypertensive therapies. J Clin Hypertens 2004, 6:76-84.
8. Friedman O., McAlister F.A., Yun L., et al. Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in ontario. Am J Med 2010, 123:173-181.
9. Adams A.S., Uratsu C., Dyer W., et al. Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users. JAMA Intern Med 2013, 173:54-61.
10. Poon I., Lal L.S., Ford M.E., et al. Racial/ethnic disparities in medication use among veterans with hypertension and dementia: a national cohort study. Ann Pharmacother 2009, 43:185-193.
11. Li W.W., Stewart A.L., Stotts N., et al. Cultural factors associated with antihypertensive medication adherence in Chinese immigrants. J Cardiovasc Nurs 2006, 21:354-362.
12. Kressin N.R., Wang F., Long J., et al. Hypertensive patients' race, health beliefs, process of care, and medication adherence. J Gen Intern Med 2007, 22:768-774.
13. Simoni J.M., Huh D., Wilson I.B., et al. Racial/ethnic disparities in ART adherence in the United States: findings from the MACH14 study. J Acquir Immune Defic Syndr 2012, 60:466-472.
14. Ishisaka D.Y., Jukes T., Romanelli R.J., et al. Disparities in adherence to and persistence with antihypertensive regimens: an exploratory analysis from a community-based provider network. J Am Soc Hypertens 2012, 6:201-209.
15. Elder K., Ramamonjiarivelo Z., Wiltshire J., et al. Trust, medication adherence, and hypertension control in Southern African American men. Am J Public Health 2012, 102:2242-2245.
16. Hsu Y.H., Mao C.L., Wey M. Antihypertensive medication adherence among elderly Chinese Americans. J Transcult Nurs 2010, 21:297-305.
17. Li W.W., Froelicher E.S. Gender differences in Chinese immigrants: predictors for antihypertensive medication adherence. J Transcult Nurs 2007, 18:331-338.
18. Taira D.A., Gelber R.P., Davis J., et al. Antihypertensive adherence and drug class among Asian Pacific Americans. Ethn Health 2007, 12:265-281.
19. Quan H., Khan N., Hemmelgarn B.R., et al. Validation of a case definition to define hypertension using administrative data. Hypertension 2009, 54:1423-1428.
20. Staffileno B.A. Treating hypertension with cardioprotective therapies: the role of ACE inhibitors, ARBs, and beta-blockers. J Cardiovasc Nurs 2005, 20:354-364.
21. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003, 362:1527-1535.
22. Statistics Canada. 2001 Census. Three-fold increase since 1981. Available at: Accessed August 8, 2013. http://www12.statcan.ca/english/census01/products/analytic/companion/etoimm/canada.cfm#threefold_increase.
23. Quan H., Wang F., Schopflocher D., et al. Development and validation of a surname list to define Chinese ethnicity. Med Care 2006, 44:328-333.
24. Harding S., Dews H., Simpson S.L. The potential to identify South Asians using a computerised algorithm to classify names. Popul Trends 1999, 97:46-49.
25. Cummins C., Winter H., Cheng K.K., et al. An assessment of the Nam Pehchan computer program for the identification of names of south Asian ethnic origin. J Public Health Med 1999, 21:401-406.
26. Motheral B.R., Fairman K.A. The use of claims databases for outcomes research: rationale, challenges, and strategies. Clin Ther 1997, 19:346-366.
27. Andrade S.E., Kahler K.H., Frech F., et al. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006, 15:565-574.
28. DiMatteo M.R., Giordani P.J., Lepper H.S., et al. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002, 40:794-811.
29. Bramley T.J., Gerbino P.P., Nightengale B.S., et al. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm 2006, 12:239-245.
30. Quan H., Sundararajan V., Halfon P., et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005, 43:1130-1139.
31. Gamble J.M., Eurich D.T., Ezekowitz J.A., et al. Patterns of care and outcomes differ for urban versus rural patients with newly diagnosed heart failure, even in a universal healthcare system. Circ Heart Fail 2011, 4:317-323.
32. Therneau T.M., Grambsch P.M. Modeling Survival Data: Extending the Cox Model (Statistics for Biology and Health) 2001, John Wiley & Sons, New York.
33. Millett C., Gray J., Bottle A., et al. Ethnic disparities in blood pressure management in patients with hypertension after the introduction of pay for performance. Ann Fam Med 2008, 6:490-496.
34. Wong M.C., Jiang J.Y., Gibbs T., et al. Factors associated with antihypertensive drug discontinuation among Chinese patients: a cohort study. Am J Hypertens 2009, 22:802-810.
35. Rosenstock I.M. Why people use health services. Milbank Mem Fund Q 1966, 44:94-127.
36. King K.M., LeBlanc P., Carr W., et al. Chinese immigrants' management of their cardiovascular disease risk. West J Nurs Res 2007, 29:804-826.
37. Lopez-Quintero C., Berry E.M., Neumark Y. Limited English proficiency is a barrier to receipt of advice about physical activity and diet among Hispanics with chronic diseases in the United States. J Am Diet Assoc 2010, 110(suppl 5):S62-S67.
38. Green A.R., Ngo-Metzger Q., Legedza A.T., et al. Interpreter services, language concordance, and health care quality. Experiences of Asian Americans with limited English proficiency. J Gen Intern Med 2005, 20:1050-1056.
39. Li W.W., Stewart A.L., Stotts N.A., et al. Cultural factors and medication compliance in Chinese immigrants who are taking antihypertensive medications: instrument development. J Nurs Meas 2005, 13:231-252.
40. Cunningham C.T., Sykes L.L., Metcalfe A., et al. Ethnicity and health literacy: a survey on hypertension knowledge among Canadian ethnic populations. Ethn Dis 2014, 24:276-282.
41. McDowell S.E., Coleman J.J., Ferner R.E. Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ 2006, 332:1177-1181.
42. Pieroni A., Sheikh Q.Z., Ali W., et al. Traditional medicines used by Pakistani migrants from Mirpur living in Bradford, Northern England. Complement Ther Med 2008, 16:81-86.
43. Tong X.L., Lian F.M., Zhou Q., et al. Prospective multicenter clinical trial of Chinese herbal formula JZQG (Jiangzhuoqinggan) for hypertension. Am J Chin Med 2013, 41:33-42.
44. Tong Y., Yu Q., Leng Y. Hypotensive effects induced by herbal fomentation at Yongquan point. J Acupunct Meridian Stud 2012, 5:305-309.
45. Hui K.K., Pasic J. Outcome of hypertension management in Asian Americans. Arch Intern Med 1997, 157:1345-1348.
46. Wright J.T., Dunn J.K., Cutler J.A., et al. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA 2005, 293:1595-1608.
47. Rasmussen J.N., Chong A., Alter D.A. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007, 297:177-186.